Research Site

West Haven, Connecticut 06516

2 studies enrolling now · 4 studies all time

What they study most

Heart Failure, Non-small Cell Lung Cancer, Non-squamous Non-small Cell Lung Cancer, Stage III Non-small Cell Lung Cancer, Unresectable

Studies at this site

• A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Squamous NSCLC — Recruiting now
• A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) — Recruiting now
• Durvalumab Alone or in Combination With Novel Agents in Subjects With NSCLC — Completed
• Registrational Study With Omecamtiv Mecarbil (AMG 423) to Treat Chronic Heart Failure With Reduced Ejection Fraction — Completed